Interaction between ovarian carcinoma cells and mesothelial cells in peritoneal dissemination
Interaction between ovarian carcinoma cells and mesothelial cells in peritoneal dissemination
批准号:
13671706
负责人:
KIKKAWA Fumitaka
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
1.The expression of dipeptidyl peptidase IV (CD26) was confirmed in endometrial cancer tissues by immunohistochemical staining. The staining intensity decreased according to undifferentiation.2.The DPPIV cDNA was transfected into ovarian cancer cells (SKOV3). Growth rate did not changed in transfected cells (SKDPIV) compared to SKOV3 or vector transfected cells (SKpcDNA). However, migration and invasion potential significantly decreased in SKDPIV cells. Adhesion rate to mesothelial cells was significantly enhanced in SKDPIV cells, but not in SKpcDNA cells. Furthermore, DPPIV transfection induced morphological change from spindle to cobblestone like shape, while morphology of SKpcDNA cells were same as SKOV3 cells with spindle shape morphology.3.IL-1b, TNFa, and VEGE, which are much in malignant ascites, could increase DPPIV expression in mesothelial cells in a dose-dependent manner, while TGFb1 reduced expression of DPPIV.4.Transfection of DPPIV into SKOV3 cells enhanced E-cadherin and b-catenin expression. Furthermore, increased MMP-2 and MT1-MMP were observed in SKDPIV cells, while TLMIP-1 and -2 were decreased.5.We inoculated these 3 types of cells into nude mice. 30 days after inoculation, a number of disseminated tumors were observed in nude mice inoculated with SKOV3 or SKpcDNA cells, but no clear dissemination was observed in nude mice inoculated with SKPCDNA cells. Finally, prolonged survival was observed in nude mice inoculated with SKDPIV cells.6.Stromal derived factor 1a (SDF-1a), one of the DPPIV substrates, could increase progression and invasion in SKOV3 cells, but not in SKDPIV cells.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fumitaka Kikkawa: "Increased Adhesion Potency of Ovarian Carcinoma Cells to Mesothelial Cells by Overexpression of Dipeptidyl Peptidase IV"International Journal of Cancer. 105・6. 779-783 (2003)
Fumitaka Kikkawa:“通过二肽基肽酶 IV 的过度表达增加卵巢癌细胞对间皮细胞的粘附效力”国际癌症杂志 105・6 (2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ei Ei Khin: "Dipeptidyl Peptidase IV Expression in Endometrial Endometrioid Adenocarcinoma and Its Inverse Correlation with Tumor Grade"American Journal of Obstetrics and Gynecology. 188・3. 670-676 (2003)
Ei Ei Khin:“子宫内膜样腺癌中二肽基肽酶 IV 的表达及其与肿瘤分级的负相关”美国妇产科杂志 188・3(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ei Ei Khin: "Neutral Endopeptidase/CD10 Expression in the Stroma of Epithelial Ovarian Carcinoma."International Journal of Gynecologic Pathology. 22・2. 175-180 (2003)
Ei Ei Khin:“上皮性卵巢癌基质中的中性内肽酶/CD10 表达。”国际妇科病理学杂志 22・2(2003 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kajiyama H, Kikkawa F, Khin E, Shibata K, Tno K, Mizutani S: "Dipeptidyl Peptidase IV Overexpression Induces Up-Regulation of E-Cadherin and Tissue Inhibitors of Matrix Metalloproteinases, Resulting in Decreased Invasive Potential in Ovarian Carcinoma Cel
Kajiyama H、Kikkawa F、Khin E、Shibata K、Tno K、Mizutani S:“二肽基肽酶 IV 过度表达诱导 E-钙粘蛋白和基质金属蛋白酶组织抑制剂上调,导致卵巢癌细胞的侵袭潜力降低
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tomomi Ito: "Ap-2 and Ikaros regulate transcription of human placental leucine aminopeptidase/oxytocinase gene"Biochem Biophys Res Cdmmun. 290. 1048-1053 (2002)
Tomomi Ito:“Ap-2 和 Ikaros 调节人胎盘亮氨酸氨基肽酶/催产素酶基因的转录”Biochem Biophys Res Cdmmun。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 34 条
An attempt to identify new antigens recognized by tumor-specific cytotoxic T lymphocytes using a HLA-modified ovarian cancer cell line as an artificial antigen presenting cell
-
批准号:24659727
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:KIKKAWA Fumitaka
-
依托单位:
Combination of stem cell research and immunotherapy in gynecologic cancer
-
批准号:22390311
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:KIKKAWA Fumitaka
-
依托单位:
Characteristic of gynecologic cancer stem cell and Epithelial-Mesenchymal Transition
-
批准号:21659383
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.18万
-
财政年份:2009
-
负责人:KIKKAWA Fumitaka
-
依托单位:
New strategy for the enhanced chemosensitivity and less metastatic potential of ovarian cancer targeting EMT inducible transcriptional factor
-
批准号:19390427
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.9万
-
财政年份:2007
-
负责人:KIKKAWA Fumitaka
-
依托单位:
New strategy for gynecologic cancer targeting of membrane-bound protease
-
批准号:16591654
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2004
-
负责人:KIKKAWA Fumitaka
-
依托单位:
Identification and Cloning of an inhibitor of Cancer Metastasis and Invasion
-
批准号:08671882
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:KIKKAWA Fumitaka
-
依托单位:
Identification and Cloning for cisplatin Resistance gene
-
批准号:06671641
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:KIKKAWA Fumitaka
-
依托单位:
Role of Oncogene and Cytochrome P450 in Carcinogenesis of Gynecologic carcinoma
-
批准号:03670776
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1991
-
负责人:KIKKAWA Fumitaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CD26阳性肿瘤相关成纤维细胞促进乳腺
癌T-DXd耐药的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:邹宇田
-
依托单位:
CD26多功能核酸适配体的构建及其在原位成像中的应用研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:王丹丹
-
依托单位:
Wnt2/β-catenin调控食管损伤中CD26表达促成纤维细胞转分化的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:何可心
-
依托单位:
TFPI在急性肺损伤中通过CD26/CXCL12/CXCR4信号通路调控间充质干细胞迁移和定植的机制研究
-
批准号:82000087
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王林林
-
依托单位:
DPP-4/CD26及其对NRF2负性调控诱导糖尿病溃疡延迟愈合作用及机制研究
-
批准号:81873648
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:隆敏
-
依托单位:
CD26/Integrinβ1调节真皮成纤维细胞异质性促进创面修复及机制研究
-
批准号:81871558
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:韩春茂
-
依托单位:
CD26调控骨髓来源细胞对脉络膜新生血管的作用及其机制研究
-
批准号:81500748
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:李红
-
依托单位:
1型糖尿病CD26在骨髓MSCs抑制CD4+T/CD8+T细胞活化中的作用及机制研究
-
批准号:81500638
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:李莉蓉
-
依托单位:
MERS-CoV与猪受体CD26结合的结构和功能研究
-
批准号:31502078
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2015
-
负责人:王奇慧
-
依托单位: